Global Sjogrens Syndrome Therapeutics Market 2023-2027

PUBLISHED: October 5, 2023

PAGES: 156 Pages

DELIVERY TIME: 1-2 business days

SELECT AN OPTION

The sjogrens syndrome therapeutics market is forecasted to grow by USD 691.09 million during 2022-2027, accelerating at a CAGR of 6.53% during the forecast period. The report on the sjogrens syndrome therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by strong drug pipeline for launching medicines, high prevalence and incidence of sjogren's syndrome, and initiatives and expected approvals of products.

Technavio's sjogrens syndrome therapeutics market is segmented as below:

Market Scope
Base Year	2022
End Year	2027
Series Year	2023-2027
Growth Momentum	Accelerate
YOY 2023	3.68%
CAGR	4%
Incremental Value	$287.68mn

By Application

Clinical
Hospital

By Type

Primary
Secondary

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the growing development of biologics as one of the prime reasons driving the sjogrens syndrome therapeutics market growth during the next few years. Also, increasing diagnostic tests and biomarkers and rising number of awareness programs will lead to sizable demand in the market.

The report on the sjogrens syndrome therapeutics market covers the following areas:

Sjogrens syndrome therapeutics market sizing
Sjogrens syndrome therapeutics market forecast
Sjogrens syndrome therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sjogrens syndrome therapeutics market vendors that include AbbVie Inc., ADVANZ PHARMA Corp., Biogen Inc., Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., GlaxoSmithKline Plc, Hikma Pharmaceuticals Plc, Horizon Therapeutics Plc, Johnson and Johnson, MorphoSys AG, Nicox S.A., Novartis AG, Otsuka Holdings Co. Ltd., RemeGen Ltd., Resolve Therapeutics LLC, Santen Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd., and TearSolutions Inc.. Also, the sjogrens syndrome therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR70328

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global sjogrens syndrome therapeutics market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global sjogrens syndrome therapeutics market 2017 - 2021 ($ million)
4.2 Application Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
4.3 Type Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Application

6.1 Market segments
Exhibit 30: Chart on Application - Market share 2022-2027 (%)
Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Clinical - Market size and forecast 2022-2027
Exhibit 34: Chart on Clinical - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Clinical - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Clinical - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Clinical - Year-over-year growth 2022-2027 (%)
6.4 Hospital - Market size and forecast 2022-2027
Exhibit 38: Chart on Hospital - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Hospital - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Hospital - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Hospital - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Application
Exhibit 42: Market opportunity by Application ($ million)
Exhibit 43: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Type

7.1 Market segments
Exhibit 44: Chart on Type - Market share 2022-2027 (%)
Exhibit 45: Data Table on Type - Market share 2022-2027 (%)
7.2 Comparison by Type
Exhibit 46: Chart on Comparison by Type
Exhibit 47: Data Table on Comparison by Type
7.3 Primary - Market size and forecast 2022-2027
Exhibit 48: Chart on Primary - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Primary - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Primary - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Primary - Year-over-year growth 2022-2027 (%)
7.4 Secondary - Market size and forecast 2022-2027
Exhibit 52: Chart on Secondary - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Secondary - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Secondary - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Secondary - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Type
Exhibit 56: Market opportunity by Type ($ million)
Exhibit 57: Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 87: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 Japan - Market size and forecast 2022-2027
Exhibit 91: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.11 UK - Market size and forecast 2022-2027
Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ million)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 ADVANZ PHARMA Corp.
Exhibit 107: ADVANZ PHARMA Corp. - Overview
Exhibit 108: ADVANZ PHARMA Corp. - Business segments
Exhibit 109: ADVANZ PHARMA Corp. - Key offerings
Exhibit 110: ADVANZ PHARMA Corp. - Segment focus
12.4 Bristol Myers Squibb Co.
Exhibit 111: Bristol Myers Squibb Co. - Overview
Exhibit 112: Bristol Myers Squibb Co. - Product / Service
Exhibit 113: Bristol Myers Squibb Co. - Key news
Exhibit 114: Bristol Myers Squibb Co. - Key offerings
12.5 Daiichi Sankyo Co. Ltd.
Exhibit 115: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 116: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibit 117: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 118: Daiichi Sankyo Co. Ltd. - Key offerings
12.6 GlaxoSmithKline Plc
Exhibit 119: GlaxoSmithKline Plc - Overview
Exhibit 120: GlaxoSmithKline Plc - Business segments
Exhibit 121: GlaxoSmithKline Plc - Key news
Exhibit 122: GlaxoSmithKline Plc - Key offerings
Exhibit 123: GlaxoSmithKline Plc - Segment focus
12.7 Hikma Pharmaceuticals Plc
Exhibit 124: Hikma Pharmaceuticals Plc - Overview
Exhibit 125: Hikma Pharmaceuticals Plc - Business segments
Exhibit 126: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 127: Hikma Pharmaceuticals Plc - Segment focus
12.8 Horizon Therapeutics Plc
Exhibit 128: Horizon Therapeutics Plc - Overview
Exhibit 129: Horizon Therapeutics Plc - Business segments
Exhibit 130: Horizon Therapeutics Plc - Key news
Exhibit 131: Horizon Therapeutics Plc - Key offerings
Exhibit 132: Horizon Therapeutics Plc - Segment focus
12.9 Johnson and Johnson
Exhibit 133: Johnson and Johnson - Overview
Exhibit 134: Johnson and Johnson - Business segments
Exhibit 135: Johnson and Johnson - Key news
Exhibit 136: Johnson and Johnson - Key offerings
Exhibit 137: Johnson and Johnson - Segment focus
12.10 MorphoSys AG
Exhibit 138: MorphoSys AG - Overview
Exhibit 139: MorphoSys AG - Product / Service
Exhibit 140: MorphoSys AG - Key offerings
12.11 Novartis AG
Exhibit 141: Novartis AG - Overview
Exhibit 142: Novartis AG - Business segments
Exhibit 143: Novartis AG - Key offerings
Exhibit 144: Novartis AG - Segment focus
12.12 Otsuka Holdings Co. Ltd.
Exhibit 145: Otsuka Holdings Co. Ltd. - Overview
Exhibit 146: Otsuka Holdings Co. Ltd. - Business segments
Exhibit 147: Otsuka Holdings Co. Ltd. - Key offerings
Exhibit 148: Otsuka Holdings Co. Ltd. - Segment focus
12.13 RemeGen Ltd.
Exhibit 149: RemeGen Ltd. - Overview
Exhibit 150: RemeGen Ltd. - Product / Service
Exhibit 151: RemeGen Ltd. - Key offerings
12.14 Resolve Therapeutics LLC
Exhibit 152: Resolve Therapeutics LLC - Overview
Exhibit 153: Resolve Therapeutics LLC - Product / Service
Exhibit 154: Resolve Therapeutics LLC - Key offerings
12.15 TearSolutions Inc.
Exhibit 155: TearSolutions Inc. - Overview
Exhibit 156: TearSolutions Inc. - Product / Service
Exhibit 157: TearSolutions Inc. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 158: Inclusions checklist
Exhibit 159: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 160: Currency conversion rates for US$
13.4 Research methodology
Exhibit 161: Research methodology
Exhibit 162: Validation techniques employed for market sizing
Exhibit 163: Information sources
13.5 List of abbreviations
Exhibit 164: List of abbreviations

Product Code: IRTNTR70328

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global sjogrens syndrome therapeutics market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Application - Market share 2022-2027 (%)
Exhibits31: Data Table on Application - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Clinical - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Clinical - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Clinical - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Clinical - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Hospital - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Hospital - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Hospital - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Hospital - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Application ($ million)
Exhibits43: Data Table on Market opportunity by Application ($ million)
Exhibits44: Chart on Type - Market share 2022-2027 (%)
Exhibits45: Data Table on Type - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Type
Exhibits47: Data Table on Comparison by Type
Exhibits48: Chart on Primary - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Primary - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Primary - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Primary - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Secondary - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Secondary - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Secondary - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Secondary - Year-over-year growth 2022-2027 (%)
Exhibits56: Market opportunity by Type ($ million)
Exhibits57: Data Table on Market opportunity by Type ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ million)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2022 and 2027
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: ADVANZ PHARMA Corp. - Overview
Exhibits108: ADVANZ PHARMA Corp. - Business segments
Exhibits109: ADVANZ PHARMA Corp. - Key offerings
Exhibits110: ADVANZ PHARMA Corp. - Segment focus
Exhibits111: Bristol Myers Squibb Co. - Overview
Exhibits112: Bristol Myers Squibb Co. - Product / Service
Exhibits113: Bristol Myers Squibb Co. - Key news
Exhibits114: Bristol Myers Squibb Co. - Key offerings
Exhibits115: Daiichi Sankyo Co. Ltd. - Overview
Exhibits116: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits117: Daiichi Sankyo Co. Ltd. - Key news
Exhibits118: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits119: GlaxoSmithKline Plc - Overview
Exhibits120: GlaxoSmithKline Plc - Business segments
Exhibits121: GlaxoSmithKline Plc - Key news
Exhibits122: GlaxoSmithKline Plc - Key offerings
Exhibits123: GlaxoSmithKline Plc - Segment focus
Exhibits124: Hikma Pharmaceuticals Plc - Overview
Exhibits125: Hikma Pharmaceuticals Plc - Business segments
Exhibits126: Hikma Pharmaceuticals Plc - Key offerings
Exhibits127: Hikma Pharmaceuticals Plc - Segment focus
Exhibits128: Horizon Therapeutics Plc - Overview
Exhibits129: Horizon Therapeutics Plc - Business segments
Exhibits130: Horizon Therapeutics Plc - Key news
Exhibits131: Horizon Therapeutics Plc - Key offerings
Exhibits132: Horizon Therapeutics Plc - Segment focus
Exhibits133: Johnson and Johnson - Overview
Exhibits134: Johnson and Johnson - Business segments
Exhibits135: Johnson and Johnson - Key news
Exhibits136: Johnson and Johnson - Key offerings
Exhibits137: Johnson and Johnson - Segment focus
Exhibits138: MorphoSys AG - Overview
Exhibits139: MorphoSys AG - Product / Service
Exhibits140: MorphoSys AG - Key offerings
Exhibits141: Novartis AG - Overview
Exhibits142: Novartis AG - Business segments
Exhibits143: Novartis AG - Key offerings
Exhibits144: Novartis AG - Segment focus
Exhibits145: Otsuka Holdings Co. Ltd. - Overview
Exhibits146: Otsuka Holdings Co. Ltd. - Business segments
Exhibits147: Otsuka Holdings Co. Ltd. - Key offerings
Exhibits148: Otsuka Holdings Co. Ltd. - Segment focus
Exhibits149: RemeGen Ltd. - Overview
Exhibits150: RemeGen Ltd. - Product / Service
Exhibits151: RemeGen Ltd. - Key offerings
Exhibits152: Resolve Therapeutics LLC - Overview
Exhibits153: Resolve Therapeutics LLC - Product / Service
Exhibits154: Resolve Therapeutics LLC - Key offerings
Exhibits155: TearSolutions Inc. - Overview
Exhibits156: TearSolutions Inc. - Product / Service
Exhibits157: TearSolutions Inc. - Key offerings
Exhibits158: Inclusions checklist
Exhibits159: Exclusions checklist
Exhibits160: Currency conversion rates for US$
Exhibits161: Research methodology
Exhibits162: Validation techniques employed for market sizing
Exhibits163: Information sources
Exhibits164: List of abbreviations